Display Settings:

Format

Send to:

Choose Destination
    Nature. 2009 Mar 5;458(7234):97-101. Epub 2009 Jan 11.

    Transcriptome sequencing to detect gene fusions in cancer.

    Source

    Michigan Center for Translational Pathology, Ann Arbor, USA.

    Abstract

    Recurrent gene fusions, typically associated with haematological malignancies and rare bone and soft-tissue tumours, have recently been described in common solid tumours. Here we use an integrative analysis of high-throughput long- and short-read transcriptome sequencing of cancer cells to discover novel gene fusions. As a proof of concept, we successfully used integrative transcriptome sequencing to 're-discover' the BCR-ABL1 (ref. 10) gene fusion in a chronic myelogenous leukaemia cell line and the TMPRSS2-ERG gene fusion in a prostate cancer cell line and tissues. Additionally, we nominated, and experimentally validated, novel gene fusions resulting in chimaeric transcripts in cancer cell lines and tumours. Taken together, this study establishes a robust pipeline for the discovery of novel gene chimaeras using high-throughput sequencing, opening up an important class of cancer-related mutations for comprehensive characterization.

    PMID:
    19136943
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2725402
    Free PMC Article

    Images from this publication.See all images (4) Free text

    Fig 3
    Fig 2
    Fig 1
    Fig. 4

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk